GLUCONORM G PLUS 2

GLUCONORM G PLUS 2 is an innovative dual-action medication formulated to aid in the effective management of blood sugar levels for individuals diagnosed with Type 2 Diabetes Mellitus. This product is particularly beneficial when dietary adjustments and exercise or monotherapy do not yield satisfactory results in controlling glucose levels. By utilizing two distinct yet collaborative pharmacological actions, GLUCONORM G PLUS 2 aims to reduce both fasting blood glucose and postprandial glucose spikes, playing a crucial role in preventing the progression of diabetes and its associated complications. Such complications include damage to the kidneys, neuropathy, visual impairment, and cardiovascular issues. The combination of Glimepiride and Metformin provides a well-rounded strategy for achieving and maintaining optimal glycemic control. Glimepiride functions by stimulating the pancreas to enhance insulin production, which is essential for glucose transport into the cells for energy. Metformin complements this action by decreasing hepatic glucose output and improving insulin sensitivity in peripheral tissues, which helps in the more efficient utilization of glucose. This strategic combination not only aids in managing blood sugar levels effectively but also helps minimize the risk of long-term diabetes-related complications, making GLUCONORM G PLUS 2 a valuable option in diabetes care. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.